1 / 14

SERUM CYTOKINE PATTERNS IN CELIAC DISEASE

SERUM CYTOKINE PATTERNS IN CELIAC DISEASE. Shabab Naqvi & Ibrahim Ibrahim Mentor: Dr. Sanil Manavalan Columbia University, College of Physicians and Surgeons. Celiac disease a digestive disease that damages the small intestine and interferes with absorption of nutrients from food

slade
Télécharger la présentation

SERUM CYTOKINE PATTERNS IN CELIAC DISEASE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SERUM CYTOKINE PATTERNS IN CELIAC DISEASE Shabab Naqvi & Ibrahim Ibrahim Mentor: Dr. Sanil Manavalan Columbia University, College of Physicians and Surgeons

  2. Celiac disease • a digestive disease that damages the small intestine and interferes with absorption of nutrients from food • it is a genetic disorder • some of the symptoms of celiac disease are diarrhea, weight loss, malnutrition, etc • when people with celiac disease eat foods containing gluten, their immune system responds by damaging the small intestine • Diagnosis is by intestinal biopsy histological grading and presence of serum auto- antibodies.

  3. Key Terms • Cytokines – soluble peptides or glycoproteins that regulate immune, inflammatory responses and other biologic processes. • Interleukin (IL) – cytokines that only affect leukocytes. • Lymphocyte – A type of leukocyte (white blood cell) of the immune system. • T-Regulatory Cell – slows down and stops immune response • T-Helper Cell (Th cell) – has antigen-receptors, releases cytokines • Natural Killer Cell – kills macrophage and bad stuff • Cytotoxic T-Cell – kills cells that produce foreign antigens such as cells infected by viruses • B-Cell – creates antibodies. • Antigen – invading microbe • Antibody– protein that fights bacteria and viruses.

  4. The Gut Lumen

  5. Inflammation & Damaged enterocytes Helper T cell Plasma cells Antibodies anti-gliadin anti-endomysial And tissue trasgliutaminase ab T cell receptor HLA-DQ2/DQ8 molecule Lymphocytes (T cells , Natural Killer cells and B cells) Cytokines (Interferon-g, TNF-a, IL-15 etc) Antigen Presenting Cell GUT LUMEN GUT LUMEN Gliadin Enterocytes LAMINA PROPRIA AND INTRA EPITHILIAL SPACE

  6. AIMS Define the serum cytokine profile in patients with Celiac Disease: A) Active Disease B) Gluten Free Diet (GFD) C) Refractory disease (RD) D) Normals/Controls

  7. METHODOLOGY Serum Samples from: A) Active Disease (25) B) Gluten Free Diet (GFD) (43) C) Refractory disease (6) D) Controls (16) Measured using a Cytokine Bio-chip Array (RANDOX laboratories Ltd) Mann-Whitney Rank test and Student T-test to determine differences in the means of individual groups of patients: Cytokines Measured: Th-1 Derived IL-2 IFN-γ Th-2 Derived IL-4 IL-6 IL-10 APC Derived IL-8, IL-1a, IL-1b, TNF-a

  8. Normal Actives GFD Refractory Normal Actives GFD Refractory IFN-g IL-4 RESULTS P = 0.01 P = 0.006 P = 0.06 IL-4 (pg/ml) P <0.005 P = 0.04 IFN-g (pg/ml) P = 0.004

  9. Th-1 Derived Th-2 Derived APC Derived ACTIVE CD VS. NORMALS Active CD n= 25 Controls n= 16

  10. GFD vs. Normals APC Derived Th-2 Derived Th-1 Derived GFD n= 43 Controls n=16

  11. Patients with Celiac Disease (AD, GFD or RD) have significantly higher levels of pro-inflammatory, TH1( (IFN-γ) and TH2 (IL-4, IL-6, IL-8) cytokines when compared to normal controls. Patients on therapy (gluten-free-diet) had fewer pro-inflammatory cytokines with elevated levels than Active disease patients SUMMARY

  12. CONCLUSIONS A better understanding of cytokine abnormalities may provide insight into: -Systemic symptoms -Disease pathogenesis -Better monitoring of disease activity -New therapeutic and prognostic modalities

  13. THANK YOU To: Dr. Sanil Manavalan Dr. Jamal Naiyer Dr. Sat Bhattacharya Harlem Children Society

More Related